BE742205A - - Google Patents

Info

Publication number
BE742205A
BE742205A BE742205DA BE742205A BE 742205 A BE742205 A BE 742205A BE 742205D A BE742205D A BE 742205DA BE 742205 A BE742205 A BE 742205A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE742205A publication Critical patent/BE742205A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BE742205D 1968-11-26 1969-11-25 BE742205A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2416068 1968-11-26

Publications (1)

Publication Number Publication Date
BE742205A true BE742205A (de) 1970-05-25

Family

ID=11212294

Family Applications (1)

Application Number Title Priority Date Filing Date
BE742205D BE742205A (de) 1968-11-26 1969-11-25

Country Status (16)

Country Link
US (1) US3660322A (de)
AT (1) AT290542B (de)
BE (1) BE742205A (de)
BR (1) BR6914433D0 (de)
CH (1) CH523892A (de)
DE (1) DE1958515B2 (de)
DK (1) DK123239B (de)
ES (1) ES373909A1 (de)
FR (1) FR2024241B1 (de)
GB (1) GB1231959A (de)
IE (1) IE33406B1 (de)
IL (1) IL33393A (de)
NL (1) NL147140B (de)
NO (1) NO123430B (de)
SE (1) SE360659B (de)
YU (1) YU33286B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE31617E (en) * 1972-02-04 1984-06-26 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
DE3815767A1 (de) * 1988-05-09 1989-11-23 Karl Niggemeier Abhefter fuer einzelblaetter
WO1993022292A1 (en) * 1992-05-07 1993-11-11 Merck & Co., Inc. New quinazolines as inhibitors of hiv reverse transcriptase
US6124302A (en) 1997-04-09 2000-09-26 Dupont Pharmaceuticals 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors
AU3199099A (en) * 1998-03-27 1999-10-18 Du Pont Pharmaceuticals Company 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors

Also Published As

Publication number Publication date
CH523892A (de) 1972-06-15
ES373909A1 (es) 1972-08-16
FR2024241A1 (de) 1970-08-28
DK123239B (da) 1972-05-29
IE33406B1 (en) 1974-06-12
SE360659B (de) 1973-10-01
IE33406L (en) 1970-05-26
YU292269A (en) 1976-03-31
FR2024241B1 (de) 1973-07-13
DE1958515B2 (de) 1976-06-24
YU33286B (en) 1976-08-31
NO123430B (de) 1971-11-15
IL33393A (en) 1973-04-30
DE1958515A1 (de) 1970-07-09
NL6917085A (de) 1970-05-28
GB1231959A (de) 1971-05-12
US3660322A (en) 1972-05-02
AT290542B (de) 1971-06-11
BR6914433D0 (pt) 1973-02-22
IL33393A0 (en) 1970-01-29
NL147140B (nl) 1975-09-15

Similar Documents

Publication Publication Date Title
AU428130B2 (de)
AU5184069A (de)
AU6168869A (de)
AU6171569A (de)
AU429879B2 (de)
AU4304568A (de)
AU4811568A (de)
AU4744468A (de)
BE725517A (de)
BE642636A (de)
BE727092A (de)
AU4503667A (de)
BE712436A (de)
BE709496A (de)
BE709484A (de)
BE709479A (de)
BE709446A (de)
BE709435A (de)
BE709415A (de)
BE709320A (de)
BE709319A (de)
BE709301A (de)
BE709274A (de)
AU4464266A (de)
BE709119A (de)